Details for Patent: 8,324,208
Which drugs does patent 8,324,208 protect, and when does it expire?
Patent 8,324,208 protects JESDUVROQ and is included in one NDA.
This patent has thirty-six patent family members in thirty-one countries.
Summary for Patent: 8,324,208
| Title: | Prolyl hydroxylase inhibitors |
| Abstract: | The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example. |
| Inventor(s): | Kevin J. Duffy, Duke M. FITCH, Jian Jin, Ronggang Liu, Antony N. Shaw, Kenneth Wiggall |
| Assignee: | GlaxoSmithKline LLC |
| Application Number: | US12/305,675 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,324,208
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-001 | Feb 1, 2023 | DISCN | Yes | No | 8,324,208 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-002 | Feb 1, 2023 | DISCN | Yes | No | 8,324,208 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-003 | Feb 1, 2023 | DISCN | Yes | No | 8,324,208 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-004 | Feb 1, 2023 | DISCN | Yes | No | 8,324,208 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Glaxosmithkline | JESDUVROQ | daprodustat | TABLET;ORAL | 216951-005 | Feb 1, 2023 | DISCN | Yes | No | 8,324,208 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,324,208
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 061570 | ⤷ Start Trial | |||
| Australia | 2007260837 | ⤷ Start Trial | |||
| Brazil | PI0713446 | ⤷ Start Trial | |||
| Canada | 2655491 | ⤷ Start Trial | |||
| China | 101505752 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
